계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
ILIAS Biologics
company
About
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $20.60M
- Industries
- Biopharma,Biotechnology,Medical Device
- Founded date
- Nov 2, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules. The company features platform technology that enables experts to load large therapeutic molecules into exosomes.ILIAS Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$20.60M
ILIAS Biologics has raised a total of
$20.60M
in funding over 2 rounds. Their latest funding was raised on
Sep 28, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 28, 2020 | Series B | $20.60M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
ILIAS Biologics is funded by 3 investors.
Asset One
and Genie Asset Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Asset One
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
